GC FLU Quadrivalent
May 24, 2022
METOJECT 30
May 24, 2022
IMUTREX 2.5
IMUTREX 2.5MG contains methotrexate which belong to a group of medicines called folate antagonist. It can be used to treat severe cases of psoriasis and rheumatoid arthritis. It can also be used to treat several kinds of cancer. Psoriasis is an autoimmune disorder that causes your skin cells to grow and multiply much quickly than normal cells. Methotrexate kills the rapidly multiplying cells in the skin. In rheumatoid arthritis, methotrexate reduce inflammation in joints by altering body’s defence mechanism in immune system. In cancer, methotrexate inhibits the enzymes responsible for nucleotide synthesis and prevents cell division.
Indications:
- Choriocarcinoma
- Rheumatoid Arthritis (RA)
- Psoriasis
Dosage:
Take Methotrexate 2.5 mg Tablet only once weekly.Mechanism of action:
Methotrexate is a folic acid antagonist; it tightly binds to dihydrofolate reductase and results in a deficiency in the cellular pools of thymidylate and purines and inhibit DNA and RNA synthesis and cell proliferation.Psoriasis clinical practice guideline 2021, strong recommended Methotrexate therapy for the treatment of moderate to severe psoriasis.(class A)
| Brand Name | |
|---|---|
| Generic Name | |
| Dosage Form | |
| Administration | |
| License Holder | |
| Key Ingredient |
OFFICE
No.27, Sharifi St. North Gandi Ave. Tehran,Iran.
Post Code: 1969813638
Tel: +98 21 88 650 472 4
Fax: +98 21 88 780 628
E-mail: info@ahranco.com
